Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Nguyen
Dana Farber Cancer Institute and ANZUP
Study Chair - Scott Williams
ANZUP and Peter MacCallum Cancer Centre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Blacktown Hospital
Blacktown, New South Wales, Australia
- Campbelltown Hospital
Campbelltown, New South Wales, Australia
- Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
- Genesis Cancer Care Newcastle
Gateshead, New South Wales, Australia
- Gosford Hospital
Gosford, New South Wales, Australia
- St George Hospital
Kogarah, New South Wales, Australia
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Orange Health Service
Orange, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- St Vincent'S Hospital
Sydney, New South Wales, Australia
- Tamworth Rural Referral Hospital
Tamworth, New South Wales, Australia
- Sydney Adventist Hospital
Wahroonga, New South Wales, Australia
- Calvary Mater Newcastle
Waratah, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Wollongong Hospital
Wollongong, New South Wales, Australia
- Genesis Cancer Care Queensland - Wesley and Chermside
Auchenflower, Queensland, Australia
- Townsville Hospital
Douglas, Queensland, Australia
- Royal Brisbane & Womens Hospital
Herston, Queensland, Australia
- Nambour General Hospital
Nambour, Queensland, Australia
- Radiation Oncology Services Mater Centre
South Brisbane, Queensland, Australia
- Icon - Gold Coast (formerly Roc Gold Coast)
Southport, Queensland, Australia
- Icon - Toowoomba (formerly Roc Toowoomba)
Toowoomba, Queensland, Australia
- Genesis Cancer Care Queensland - Tugun and Southport
Tugun, Queensland, Australia
- Princess Alexandra Hospital Brisbane
Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- Ashford Cancer Centre Research (adelaide Cancer Centre)
Kurralta Park, South Australia, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- Peter Maccallum Cancer Centre
Bendigo, Victoria, Australia
- Peter Maccallum Cancer Centre (moorabbin Campus)
Bentleigh East, Victoria, Australia
- Eastern Health (box Hill Hospital)
Box Hill, Victoria, Australia
- Genesis Care - Epping (formerly Eroc)
Epping, Victoria, Australia
- Genesis Care - Western (formerly Wroc)
Footscray, Victoria, Australia
- Genesis Care - Frankston (formerly Froc)
Frankston, Victoria, Australia
- Austin Health
Heidelberg, Victoria, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- Epworth Healthcare - Richmond
Richmond, Victoria, Australia
- Genesis Care - Ringwood (formerly Rroc)
Ringwood East, Victoria, Australia
- Sunshine Hospital
St Albans, Victoria, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2014
- Primary completion
- 30 Jun 2026
- Completion
- 30 Jun 2026
- Last update posted
- 6 May 2026
- Registered enrollment
- 802
- Registry id
- NCT02446444
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.